M&A Deal Summary

FHI Clinical Acquires TCD Global

On December 2, 2021, FHI Clinical acquired life science company TCD Global

Acquisition Highlights
  • This is FHI Clinical’s 1st transaction in the Life Science sector.
  • This is FHI Clinical’s 1st transaction in South Africa.

M&A Deal Summary

Date 2021-12-02
Target TCD Global
Sector Life Science
Buyer(s) FHI Clinical
Deal Type Add-on Acquisition

Target

TCD Global

Centurion, South Africa
TCD Global is a Contract Research Organisation that has been awarded over 300 clinical trial contracts, across 16 therapeutic areas, by more than 120, predominantly international, clients. TCD Global was founded in 2000 and is based in Centurion, South Africa.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

FHI Clinical

Durham, North Carolina, United States

Category Company
Founded 2019
Sector Life Science
DESCRIPTION

FHI Clinical is a full-service contract research organization (CRO) with global expertise, responsive approaches, and proven solutions to manage complex clinical research around the world. FHI Clinical was founded in 2019 and is based in Durham, North Carolina.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: South Africa M&A 1 of 1
Year: 2021 M&A 1 of 1